Welcome to LookChem.com Sign In|Join Free

CAS

  • or

82689-19-8

Post Buying Request

82689-19-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

82689-19-8 Usage

Chemical Properties

White to off-white powder

Check Digit Verification of cas no

The CAS Registry Mumber 82689-19-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,2,6,8 and 9 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 82689-19:
(7*8)+(6*2)+(5*6)+(4*8)+(3*9)+(2*1)+(1*9)=168
168 % 10 = 8
So 82689-19-8 is a valid CAS Registry Number.
InChI:InChI=1/C16H22N2O3/c1-16(2,3)21-15(20)18-12(10-19)8-11-9-17-14-7-5-4-6-13(11)14/h4-7,9,12,17,19H,8,10H2,1-3H3,(H,18,20)/t12-/m0/s1

82689-19-8 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (B4287)  Nα-(tert-Butoxycarbonyl)-L-tryptophanol  >98.0%(HPLC)(N)

  • 82689-19-8

  • 1g

  • 790.00CNY

  • Detail
  • TCI America

  • (B4287)  Nα-(tert-Butoxycarbonyl)-L-tryptophanol  >98.0%(HPLC)(N)

  • 82689-19-8

  • 5g

  • 2,100.00CNY

  • Detail
  • Alfa Aesar

  • (H66571)  N-Boc-L-tryptophanol, 95%   

  • 82689-19-8

  • 250mg

  • 245.0CNY

  • Detail
  • Alfa Aesar

  • (H66571)  N-Boc-L-tryptophanol, 95%   

  • 82689-19-8

  • 1g

  • 735.0CNY

  • Detail
  • Alfa Aesar

  • (H66571)  N-Boc-L-tryptophanol, 95%   

  • 82689-19-8

  • 5g

  • 2940.0CNY

  • Detail
  • Aldrich

  • (514306)  N-α-(tert-Butoxycarbonyl)-L-tryptophanol  98%

  • 82689-19-8

  • 514306-1G

  • 1,615.77CNY

  • Detail
  • Aldrich

  • (514306)  N-α-(tert-Butoxycarbonyl)-L-tryptophanol  98%

  • 82689-19-8

  • 514306-5G

  • 7,160.40CNY

  • Detail

82689-19-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name N-alpha-BOC-L-tryptophanol

1.2 Other means of identification

Product number -
Other names tert-butyl N-[(2S)-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl]carbamate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:82689-19-8 SDS

82689-19-8Relevant articles and documents

Total syntheses of Hexahydropyrrolo[2,3-b]indole Alkaloids, (+)-pseudophrynamine 270 and (+)-pseudophrynamine 272A

Maity, Arindam,Munda, Mintu,Niyogi, Sovan,Kumar, Nivesh,Bisai, Alakesh

, (2021/12/09)

A general strategy for asymmetric approach to the hexahydropyrrolo[2,3-b]indole alkaloids sharing a vicinal quaternary-tertiary centers has been disclosed via Pd(0)-catalyzed N-deacylative allylations (N-DaA) (dr > 20:1). Utilizing this strategy, asymmetric total syntheses of pseudophrynamines 270 (3c) and 272A (3b) have been achieved from a 3-substituted N-acyl indole 8 (pro-nucleophile) with allyl alcohol (pro-electrophile).

ANTIBODY DRUG CONJUGATES COMPRISING ECTEINASCIDIN DERIVATIVES

-

Page/Page column 182, (2020/05/29)

Drug conjugates having formula [D-(X) b -(AA) w -(T) g -(L)-] n -Ab wherein: D is a drug moiety having the following formula (I) or a pharmaceutically acceptable salt, ester, solvate, tautomer or stereoisomer th

Synthesis, biological evaluation, and molecular modeling studies of chiral chloroquine analogues as antimalarial agents

Kondaparla, Srinivasarao,Debnath, Utsab,Dola, Vasantha Rao,Sinha, Manish,Katti, Seturam B.,Soni, Awakash,Srivastava, Kumkum,Puri, Sunil K.

, (2019/01/05)

In a focused exploration, we designed, synthesized, and biologically evaluated chiral conjugated new chloroquine (CQ) analogues with substituted piperazines as antimalarial agents. In vitro as well as in vivo studies revealed that compound 7c showed potent activity (in vitro 50% inhibitory concentration, 56.98 nM for strain 3D7 and 97.76 nM for strain K1; selectivity index in vivo [up to at a dose of 12.5 mg/kg of body weight], 3,510) as a new lead antimalarial agent. Other compounds (compounds 6b, 6d, 7d, 7h, 8c, 8d, 9a, and 9c) also showed moderate activity against a CQ-sensitive strain (3D7) and superior activity against a CQ-resistant strain (K1) of Plasmodium falciparum. Furthermore, we carried out docking and three-dimensional quantitative structure-activity relationship (3D-QSAR) studies of all in-house data sets (168 molecules) of chiral CQ analogues to explain the structure-activity relationships (SAR). Our new findings specify the significance of the H-bond interaction with the side chain of heme for biological activity. In addition, the 3D-QSAR study against the 3D7 strain indicated the favorable and unfavorable sites of CQ analogues for incorporating steric, hydrophobic, and electropositive groups to improve the antimalarial activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 82689-19-8